GXGushang Xia

Gushang Xia

*This is an algorithmically generated author record based on publicly available information.

Gushang Xia has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Honggang Luo

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication
  • Jiannan Shao

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication
  • Qingli Kong

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication
  • Rong Yang

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication
  • Shenyu Luo

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication
  • Xianglin Li

    Department of Orthopaedics, The People’s Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China

    1 shared publication

Latest Publications

  • Open Access

    Sex hormone–binding globulin increases lumbar fracture risk via bone density, inflammation, and insulin pathways

    by Gushang Xia, Rong Yang, Yusong Zhou, Shenyu Luo, Jiannan Shao, Qingli Kong, Honggang Luo, Xianglin Li

    Circulating sex hormone–binding globulin (SHBG) regulates bioavailable sex hormones that influence bone metabolism. We investigated whether genetically higher SHBG increases lumbar fracture (LF) risk and identified the biological pathways mediating this effect, including bone mineral density (BMD), C-reactive protein (CRP), and insulin use. A two-sample bidirectional and mediation Mendelian randomization (MR) framework was applied using genome-wide significant single-nucleotide polymorphisms ( P < 5 × 10 −8 ) from large-scale genome-wide association study datasets (FinnGen, UK Biobank, and IEU OpenGWAS). Instrumental variables were linkage disequilibrium-pruned ( r 2 < 0.01), and analyses were conducted using inverse-variance weighted, MR-Egger, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier methods. Genetically predicted SHBG was causally associated with higher LF risk (FinnGen: odds ratio [OR] = 1.201; 95% confidence interval, 1.028–1.404; P = .021; UK Biobank: OR = 1.005; 95% confidence interval, 1.002–1.008; P = .002). SHBG showed significant negative effects on lumbar BMD (OR = 0.934; P = .0029) and CRP (OR = 0.921; P = .0065), and a modest decrease in insulin medication use (OR = 0.9963; P = 6.1 × 10 −6 ). Mediation analysis revealed that 64.8% of SHBG’s total effect on LF was mediated through BMD, 63.8% through CRP, and 38.7% through insulin pathways. Sensitivity tests confirmed robustness without evidence of pleiotropy. Genetically elevated SHBG increases LF risk mainly through impaired bone density and systemic inflammation. These findings suggest that interventions targeting SHBG-related metabolic pathways may help reduce skeletal fragility.